There is conflicting evidence on the association between PCOS and early and late obstetric complications. It is unclear if the reported risks are independent of BMI, preexisting hypertension and diabetes. We performed a retrospective chart review to examine the risk of early and late obstetrical complications after IVF in women with PCOS (n=130) compared to controls (n=130). The miscarriage rate was 17.7% in PCOS women and 15.4% in controls. PCOS was not associated with miscarriage independent of age and BMI. The prevalence of gestational DM (GDM) was similar in both groups (12% PCOS versus 11% controls). BMI was independently associated with GDM (p=0.01). Risk of both preeclampsia and PIH was 10% in PCOS and 5% in controls, but not statistically significant. Preexisting HTN showed a significant association with preeclampsia (p<0.01). There was no significant difference in preterm delivery, twin gestation, intrauterine fetal death and intrauterine growth restriction in the 2 groups. Our study did not detect an increased risk of miscarriage in women with PCOS undergoing IVF. Obesity was a significant contributor to late obstetric complications, namely GDM. These findings warrant counseling of women with PCOS especially prior to IVF on the potential benefits of weight loss prior to pregnancy.
ABSTRACT
There is conflicting evidence on the association between PCOS and early and late obstetric complications. It is unclear if the reported risks are independent of BMI, preexisting hypertension and diabetes. We performed a retrospective chart review to examine the risk of early and late obstetrical complications after IVF in women with PCOS (n=130) compared to controls (n=130). The miscarriage rate was 17.7% in PCOS women and 15.4% in controls. PCOS was not associated with miscarriage independent of age and BMI. The prevalence of gestational DM (GDM) was similar in both groups (12% PCOS versus 11% controls). BMI was independently associated with GDM (p=0.01). Risk of both preeclampsia and PIH was 10% in PCOS and 5% in controls, but not statistically significant. Preexisting HTN showed a significant association with preeclampsia (p<0.01). There was no significant difference in preterm delivery, twin gestation, intrauterine fetal death and intrauterine growth restriction in the 2 groups. Our study did not detect an increased risk of miscarriage in women with PCOS undergoing IVF. Obesity was a significant contributor to late obstetric complications, namely GDM. These findings warrant counseling of women with PCOS especially prior to IVF on the potential benefits of weight loss prior to pregnancy.
Summary for Lay Readers
There is conflicting evidence on the association between polycystic ovary syndrome (PCOS) and early and late pregnancy complications. It is unclear if the reported risks are independent of maternal weight and medical conditions such as preexisting hypertension and diabetes. We performed a study to examine the risk of early and late pregnancy complications after in vitro fertilization in a large group of women with PCOS (n=130) compared to controls (n=130). The miscarriage rate was similar in PCOS women and controls. PCOS was not associated with miscarriage independent of age and BMI. The prevalence of gestational DM (GDM) was also similar in both groups (12% PCOS versus 11% controls). PCOS was not associated with GDM, however, maternal weight was significantly associated with GDM. Risk of both pre-eclampsia and pregnancy induced hypertension was 10% in PCOS and 5% in controls, but not statistically significant. Women with preexisting hypertension had a higher risk of developing preeclampsia. There was no significant difference in preterm delivery, Cesarean section, twin gestation, intrauterine fetal death and intrauterine growth restriction in the 2 groups. Our study shows that obesity was a significant contributor to pregnancy complications such as gestational diabetes. These findings may warrant aggressive counseling of women with PCOS on the potential benefits of weight loss prior to pregnancy.
INTRODUCTION
Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders affecting women of childbearing age, with an estimated prevalence of about 5-10% as reported in population-based studies 1 . PCOS is a chronic disorder associated with both reproductive complications and early onset metabolic morbidities 2 . Women with PCOS can be very successful in achieving a pregnancy after treatment with ovulation induction drugs 3 . Our primary aim was to determine the risk of early obstetric complications such as spontaneous miscarriage and late complications such as GDM, PIH, preeclampsia and preterm delivery (PTD) in a large group of women with PCOS compared to controls. Our secondary aim was to determine the effects of PCOS on neonatal outcomes.
METHODS
We reviewed pregnancy outcomes in women with PCOS (n=130) and controls (women with tubal factor infertility, n=130) who had in vitro fertilization (IVF) between 1995 and 2007 at the University of Iowa Hospitals & Clinics. Subjects who had a diagnosis of PCOS based on the 2003 Rotterdam criteria (presence of at least two of the following three criteria: oligomenorrhea (<9 cycles/year), clinical and/or biochemical signs of hyperandrogenism, and polycystic ovaries on ultrasound) were included in the study 11 . Subjects who had a two step approach to screening for gestational diabetes were included in the study. An initial screen was performed by measuring the 1 hour glucose level after a 50g oral glucose load. The 3 hour oral glucose tolerance test (GTT) was performed if the screening level was >140mg/dl. Gestational diabetes mellitus (GDM) was defined as two or more abnormal blood glucose levels on a 3 hour GTT (fasting ≥ 95mg/dl, 1hr level≥ 180mg/dl, 2hr level ≥ 155mg/dl, 3hr level ≥ 140mg/dl) 12 . Pregnancy induced hypertension (PIH) was defined as blood pressure ≥ 140/90 mmHg after 20 weeks gestation without proteinuria and with normal blood pressure prior to pregnancy. Preeclampsia was defined as blood pressure ≥ 140/90 mmHg after 20 weeks gestation and proteinuria (>300mg) determined on a 24 hour urine collection.
This information was abstracted from the medical records and IVF database. Subjects with incomplete obstetric records were excluded from the study. Control subjects with only tubal factor infertility were selected consecutively from the IVF database to match the similar time period, age (+/-5 years) and BMI (+/-2) of the PCOS subjects.
Other variables that were compared included gravidity, parity, current smoking, pre-existing diabetes, hypertension and use of medications to treat these latter conditions. Prior to the current pregnancy impaired fasting glucose (IFG) was defined as having a fasting blood glucose level of 100-125mg/dL and diabetes was defined as glucose ≥126mg/dl. For subjects who had a 2h GTT, impaired glucose tolerance (IGT) was defined as 2 hour glucose level of 140-199mg/dl and diabetes was defined as glucose ≥200mg/dl. Antepartum outcomes analyzed included miscarriage rate (loss before 20 weeks gestation), GDM, PIH, preeclampsia, preterm delivery (PTD <37 weeks), intrauterine growth restriction (IUGR,) and intrauterine fetal demise (IUFD).
Intrapartum and neonatal outcomes were also compared between control and study groups.
The Wilcoxon rank sum test was used to evaluate differences between continuous variables and the Fisher exact test and Chi-squared test was performed for categorical variables to compare demographic data between the PCOS group and controls. Multiplelogistic regression analysis was performed to control for variables that significantly differed in the two groups. Statistical significance was defined as p < 0.05. We had 80% power to detect a 2 fold difference in miscarriage rates between women with PCOS and controls at the 0.05 significance level. This study was approved by the University of Iowa Institutional Review Board.
RESULTS

Demographics
Women with PCOS were slightly younger (mean age 31.1±4.3years than controls 33±3.7years), and had a higher prepregnancy BMI compared to the controls (mean BMI 31±8 vs. controls 28.9±5.5, p<0.05, Table 1 ). The PCOS subjects had fewer prior pregnancies and miscarriages than the controls. However, women with PCOS had a higher miscarriage rate per pregnancy 50% (42/85) compared to that in controls 24% (81/341, p<0.01). Similar proportions of women with PCOS and controls had preexisting hypertension (10% vs 6%) and hypothyroidism (10% vs 7%). In the PCOS group 29% had IFG/IGT and 5% had type 2 diabetes. A higher proportion of women with PCOS had taken insulin sensitizing agents, namely metformin, prior to the current pregnancy compared to controls (23.9% vs 0.8%). All 5 subjects with DM, 9/30 subjects with IFG/IGT and 14 other subjects were prescribed metformin. The majority of women with PCOS (54%) met all three diagnostic criteria namely oligomenorrhea, hyperandrogenism and polycystic ovaries. 
Late Obstetric complications
Gestational Diabetes: The percentage of women with ongoing pregnancy beyond 20 weeks who developed GDM was not significantly different in the two groups, PCOS 12.2% (13/102) and controls 10.9% (12/109) (p=0.78, Table  2 ). The subjects with preexisting diabetes (PCOS 5, controls 1) were not included in this analysis. The logistic regression model for GDM with PCOS, age, and BMI as independent variables showed that BMI was significantly associated with GDM after adjusting for age and diagnosis of PCOS (OR 1.44, 95% CI: 1.09-1.92, p<0.01). PCOS was not found to be significantly associated with GDM (p=0.678) after adjusting for age and BMI. PCOS women with singletons (n=73) had a 15.1% prevalence of GDM compared to 13.2% in controls with singletons (n=76, Table  3 ). The rate of multiple pregnancy was similar in both groups, 32% (34) in PCOS and 31% (29) in controls (Table  3) . Of the 25 PCOS women with IFG/IGT with ongoing pregnancies, 5 developed GDM (20%) and three of the latter women had been treated with metformin prior to pregnancy.
Pregnancy induced hypertension/preeclampsia:
The prevalence of PIH was two times higher in women with PCOS than that of controls (10.28% vs. 5.45%, p=0.186, Table II ) as was the prevalence of preeclampsia (PCOS 10.28% compared to controls 5.45%, Table 2 ).
The association between PCOS and PIH after adjusting for the effect of smoking was not significant (p=0.073). Preexisting hypertension had a significant association with development of preeclampsia in both groups (OR 5.02, 95% CI: 1.39-18.16, p<0.01). Also, nulligravidity had a strong association with the development of preeclampsia in both groups (OR 7.30, 955 CI: 1.97, 27.04, p<0.003). PCOS was not found to be significantly associated with preeclampsia after adjusting for any of the above covariates.
Preterm Delivery: The overall risk of PTD was 26% in women with PCOS compared to 26% in controls (p=0.9, Table 2 ). PCOS was not found to be significantly associated with PTD after adjusting for multiple pregnancy, age, BMI, and parity (p=0.6). Twin gestation had a significantly higher risk of PTD in the PCOS and control groups (OR 13.31, 95% CI: 5.98-29.6, p<0.001, Table 3 ). In addition, BMI also had a significant association with PTD (OR 1.34, 955 CI: 1.03-1.76, p<0.03). 
Neonatal & Intrapartum Outcomes:
Women with PCOS had a total of 107 deliveries and controls had 110 deliveries. There was no significant difference in delivery mode in either group, with approximately 44% women delivering by cesarean section ( Table  4) . The mean birth weights of both singletons and twin gestation did not differ between groups and the incidence of macrosomia (birth weight>4000g) was not statistically different in infants of controls compared to infants of women with PCOS. The risk of IUGR was higher in the control group compared to the PCOS group, however the numbers in each group were small and not significantly different (p=0.68). 
DISCUSSION
Women with PCOS need to be accurately counseled regarding their obstetric risks especially if some of these risks can be modified by interventions such as weight loss. We included a large group of well defined subjects with PCOS undergoing IVF and attempted to match them based on key factors such as age and BMI. After using logistic regression for confounding factors our study did not show an increased risk of miscarriage in women with PCOS independent of BMI. This supports previous data from a metaanalysis of nine studies that reported no significant difference in miscarriage rates between PCOS and non-PCOS patients after IVF (random effects OR 1.0; 95% CI 0.5 to 1.8) 13 . The results of the meta-analysis were however limited in that not all studies were matched for age or BMI and most included multiple cycles from one subject. Regardless of the method of conception women with a BMI ≥ 25 have been shown to have a significantly higher odds of miscarriage (OR 1.67; 95% CI, 1.25-2.25) 14 . In IVFconceived pregnancies, women with a BMI ≥ 30 had a higher risk of miscarriage compared to women with a BMI < 30 (OR 1.53, 95% CI 1.27-1.84 (p <0.001) 15 . The current literature indicates that, regardless of the method of conception, miscarriage risk is related to obesity rather than PCOS or any other cause of infertility.
Higher multiple pregnancy rate, parity and BMI in women with PCOS were important risks contributing to the development of GDM 10 . Our study showed that BMI was an independent risk factor for the development of GDM after controlling for age and PCOS diagnosis. The independent risk of GDM in women with PCOS has been investigated in several populations but remains controversial. In a Finnish study 99 women with PCOS (ultrasound appearance of polycystic ovaries and hyperandrogenism, with or without irregular menses) were compared to 737 geographically matched controls 16 . The risk of developing GDM was largely explained by obesity and the independent association with PCOS could not be demonstrated in singleton pregnancies. In a Czech study including PCOS women (n=66) and age and weight matched controls (n=66) no difference was detected in the risk of GDM 17 . A recent population-based U.S. study reported a higher prevalence of GDM among women with PCOS (n=1,542) compared to controls (OR 2.4, 95% CI: 2.1-2.83) 18 . However, despite its large sample size, a major drawback of this study was that BMI was not included in the analysis. A recent metaanalysis of five studies demonstrated a higher risk of developing GDM in women with PCOS (OR 3.66, 95% CI: 1.20-11.16) however, significant statistical heterogeneity was present in these studies 10 .The risk of developing GDM in all women is reported to be about two, four, and eight times higher based on overweight, obese, and severely obesity respectively, compared with normalweight 19 . Larger studies are therefore needed in a well characterized PCOS population to determine the independent risk of GDM.
Our study suggests a possible association between PCOS and PIH but was limited by sample size.
As expected preexisting hypertension and nulliparity was associated with increased risk of preeclampsia. The prevalence of preeclampsia appears to be two-fold greater in women with PCOS, but was not statistically significant in our study. In a recent study of women with PCOS a subgroup analysis of only two higher validity studies was performed and reported a significantly increased risk of PIH (OR 3.71, 95% CI: 1.72-17.49) 10 . In the same study women with PCOS also demonstrated a significantly higher chance of developing preeclampsia (OR 3.47, 95% CI: 1.95-6.17). However, no subgroup analysis could be performed as variables such as parity, BMI and multiple pregnancy differed in the studies included.
As reported in previous studies we did not find an increased risk of PTD delivery independent of multiple gestations in women with PCOS 10 . Similarly we did not find an increased risk of macrosomia or SGA in children born to women with PCOS. Studies have demonstrated an increased risk of poor obstetric outcomes (preterm delivery, low birth weight) in singleton pregnancies resulting from IVF 20, 21 . Both groups in our study conceived after IVF thereby controlling for any confounding effect.
In summary our study demonstrates that the miscarriage rate in women with PCOS after IVF is not increased independent of BMI. However, BMI alone was significantly associated with increased risk of gestational diabetes. Preexisting hypertension in the PCOS population was associated with an increased risk of preeclampsia. These findings underscore the need for clinicians to diligently screen women with PCOS for the presence of obesity and hypertension. Physicians have an opportunity to screen women prior to assisting conception and offer nutritional counseling and weight loss strategies. Obese women with PCOS should be monitored closely in pregnancy for the development of GDM, PIH and preeclampsia. Accurate identification of these morbidities in pregnancy is critical as the affected group of women may also be at increased risk for hypertension, heart disease and cardiovascular events later in life 22, 23 .
Future studies should aim to examine the effects of interventions such as prepregnancy weight loss on miscarriage rate and risk of GDM in women with PCOS.
